All In MedTech

Device Trial Radar · NCT06915818

Flexagon Plus OTOLoc Colon Anastomosis in Patients Undergoing Surgery

GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Ileo-colic and Colo-colonic Anastomoses in Patients Undergoing Surgical Procedures

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

65

Planned (sponsor's estimate)

Start

Mar 29, 2025

Primary completion

Feb 2027

Study completion Apr 2027

Sponsor

Lead sponsor
GI Windows, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon SFM system plus OTOLoc when used to create a Ileo-colic and Colo-colonic anastomoses in participants undergoing colon surgery.

Conditions

  • Colon Anastomosis

Interventions

  • Ileo-colic and colo-colonic Anastomosis with Flexagon SFM and OTOLocDevice

    This study will investigate two types of intervention: ileo-colic and colo-colonic anastomosis creation in subjects undergoing colon surgery. Flexagon SFMs and OTOLoc devices will be delivered laparoscopically and/or endoscopically into a portion of either the ileum or the colon that are intended to be anastomosed. An OTOLoc device will be deployed into the ileum/colon wall to provide access for the deployment of a Flexagon SFM into the bowel. The process is repeated at an intended section of colon. Once deployed, the Flexagon SFMs are approximated and positioned, after which the SFMs are couple together to form the anastomosis, with the OTOLoc devices allowing fluidic communication between the two lumens until the anastomosis is fully formed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Successful Anastomosis Creation without the Need for ReoperationTime frame: 30 Days

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinica Colonial Hospital

    Santiago, Huechuraba, Región Metropolitana, Chile

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.